-
1
المؤلفون: Paul Monagle, Anthonie W A Lensing, Kirstin Thelen, Ida Martinelli, Christoph Male, Amparo Santamaría, Elena Samochatova, Riten Kumar, Susanne Holzhauer, Paola Saracco, Paolo Simioni, Jeremy Robertson, Gernot Grangl, Jacqueline Halton, Phillip Connor, Guy Young, Angelo C Molinari, Ulrike Nowak-Göttl, Gili Kenet, Stefanie Kapsa, Stefan Willmann, Akos F Pap, Michael Becka, Teresa Twomey, Jan Beyer-Westendorf, Martin H Prins, Dagmar Kubitza, Werner Streif, Jorge Carniero, Sandra Logetto, Leonardo Brandao, Pascal Amedro, Damien Bonnet, Sven Dietrich, Krisztian Kallay, Shoshana Revel-Vilk, Hannah Tamary, Paola Giordano, Maria Abbattista, Andrea Artoni, Daniela Tormene, Hiroshi Ono, Maroeska WM Te Loo, Heleen Van Ommen, Margreet A Veening, Monique H Suiker, Marjolein Peters, Anastasia Shamardina, Nizhny Novgorod, Lyudmila Zubarovskaya, Maria A Dasi, Maria Elorza, Amparo Santamaria, Manuel Sánchez-Luna, Manuela Albisetti, Sebastian Grunt, Kaan Kavakli, Tina Biss, Philip Connor, Mike Williams, Suchitra Acharya, Rumi Bhat, Susan Kearney, Kavita Patel, Madvi Rajpukar, Jeffrey H Schwartz, Terry Vik, Tung Wynn, Donald L Yee
المساهمون: MUMC+: KIO Kemta (9), Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, Pediatric surgery
المصدر: The Lancet Haematology, 6(10), E500-E509. ELSEVIER SCI LTD
Lancet Haematology
r-FISABIO. Repositorio Institucional de Producción Científica
instname
The Lancet Haematology, 6(10), e500-e509. Lancet Publishing Group
Monagle, P, Lensing, A W A, Thelen, K, Martinelli, I, Male, C, Santamaría, A, Samochatova, E, Kumar, R, Holzhauer, S, Saracco, P, Simioni, P, Robertson, J, Grangl, G, Halton, J, Connor, P, Young, G, Molinari, A C, Nowak-Göttl, U, Kenet, G, Kapsa, S, Willmann, S, Pap, A F, Becka, M, Twomey, T, Beyer-Westendorf, J, Prins, M H, Kubitza, D & EINSTEIN-Jr Phase 2 Investigators 2019, ' Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies ', The Lancet Haematology, vol. 6, no. 10, pp. e500-e509 . https://doi.org/10.1016/S2352-3026(19)30161-9مصطلحات موضوعية: Male, Pediatrics, Fondaparinux, 0302 clinical medicine, Rivaroxaban, Drug Dosage Calculations, DEEP-VEIN THROMBOSIS, Young adult, Adolescent, Anemia, Anticoagulants, Body Weight, Child, Child, Preschool, Drug Administration Schedule, Factor Xa, Female, Half-Life, Hemorrhage, Humans, Infant, Neutropenia, Prothrombin Time, Treatment Outcome, Venous Thromboembolism, Hematology, Vitamin K antagonist, REPORTED TREATMENT SATISFACTION, ORAL RIVAROXABAN, 030220 oncology & carcinogenesis, medicine.symptom, medicine.drug, medicine.medical_specialty, medicine.drug_class, Asymptomatic, 03 medical and health sciences, medicine, Dosing, Preschool, business.industry, medicine.disease, XA INHIBITOR RIVAROXABAN, Clinical trial, DEFINITION, ATRIAL-FIBRILLATION, business, STANDARD THERAPY, 030215 immunology
-
2
المصدر: Pharmacogenomics, 18, 501-513
Pharmacogenomics, 18, 5, pp. 501-513مصطلحات موضوعية: 0301 basic medicine, Databases, Factual, medicine.medical_treatment, Antineoplastic Agents, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Bioinformatics, Germline, 03 medical and health sciences, 0302 clinical medicine, Glioma, Genetics, Overall survival, Humans, Medicine, Adverse effect, Pharmacology, Medulloblastoma, Chemotherapy, Adult Germline Stem Cells, Brain Neoplasms, business.industry, Genetic Variation, medicine.disease, Pharmacogenomic Testing, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Molecular Medicine, Personalized medicine, business, Pharmacogenetics, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5]
وصف الملف: application/pdf